TITLE

Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U)

AUTHOR(S)
Orellana, J; Teich, S A; Winterkorn, J S; Mathur-Wagh, U; Handwerger, S; Schlamm, H; Malamud, S C; Yancovitz, S R; Cederberg, D M; Mildvan, D S
PUB. DATE
July 1988
SOURCE
British Journal of Ophthalmology;Jul1988, Vol. 72 Issue 7, p525
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66062366

 

Related Articles

  • Maintenance therapy for CMV retinitis.  // Modern Medicine;Apr95, Vol. 63 Issue 4, p27 

    Reports that the Food and Drug Administration has approved ganciclovir capsules as an alternative to the intravenous formulation for the maintenance treatment of cytomegalovirus retinitis. Indications and side effects of the ganciclovir capsules.

  • Two-drug treatment is effective against recurrent CMV retinitis.  // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p131 

    Reports on the effectiveness of the combination of the drugs foscarnet and ganciclovir in the treatment of cytomegalovirus (CMV retinitis. Precautions in the use of the two-drug therapy.

  • Local ganciclovir therapy target of CMV retinitis studies. Kwun, Robert C. // Ophthalmology Times;06/15/98, Vol. 23 Issue 12, p25 

    Focuses on research trials using ganciclovir to treat cytomegalovirus (CMV) retinitis. Role of CMV retinitis in causing infectious retinitis; treatment of CMV retinitis through systemic therapy and local therapy; Composition of systemic therapy including ganciclovir, foscarnet and cidofovir;...

  • Valganciclovir: A Viewpoint by Sharon Walmsley. Walmsley, S. // Drugs;Jun2001, Vol. 61 Issue 8, p1151 

    Comments on the effectiveness of an antiviral drug known as ganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients. Concerns of patients regarding the need for long term intravenous treatment; Limitations of oral ganciclovir treatment; Complications associated with...

  • Use of oral ganciclovir for cytomegalovirus retinitis.  // American Family Physician;1/1/1996, Vol. 53 Issue 1, p363 

    Discusses the article `Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS,' by W.L. Drew et al, published in `North England Journal of Medicine.' Efficacy and safety of oral ganciclovir for the treatment of cytomegalovirus retinitis in patients with...

  • ORAL CMV TREATMENT EFFECTIVE.  // AIDS Patient Care & STDs;Jun2002, Vol. 16 Issue 6, p305 

    Examines the efficacy of valganciclovir in treating cytomegalovirus retinitis in patient with AIDS. Conversion of the oral drug to ganciclovir in the body following intake; Demonstration of disease progression on patients treated with the drug; Achievement of a satisfactory treatment response...

  • Intraocular implant for cytomegalovirus retinitis.  // American Family Physician;6/1/1996, Vol. 53 Issue 8, p2764 

    Reports that the Food and Drug Administration has approved an intraocular implant called Vitrasert for the treatment of cytomegalovirus retinitis in AIDS patients. Direct delivery of ganciclovir to the eye.

  • ganciclovir.  // Davis's Drug Guide for Nurses, 9th edition;2005, p468 

    Provides information on ganciclovir, an antiviral agent used for the treatment of cytomegalovirus retinitis in immunocomprised patients. Pharmacokinetics; Contraindications and precautions; Adverse reactions and side effects; Prescribed dosage.

  • MEDICAL BRIEFS.  // Advocate;5/18/93, Issue 629, p39 

    Reports on the phase 3 trials of ganciclovir eye implants to treat cytomegalovirus retinitis.

  • Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient. Okamoto, T; Okada, M; Mori, A; Saheki, K; Takatsuka, H; Wada, H; Tamura, A; Fujimori, Y; Takemoto, Y; Kanamaru, A; Kakishita, E // Bone Marrow Transplantation;11/1/97, Vol. 20 Issue 9, p801 

    A female patient with ALL received a bone marrow transplant (BMT) from an unrelated donor with a one locus HLA mismatch. The donor was heterozygous at the HLA-A locus, while the patient was homozygous at this locus. The patient had cytomegalovirus (CMV) antigenemia on day 42 following an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics